WHO ICTRP trial
Implementation of first-trimester screening and prevention of preeclampsia
JPRN-jRCTs041190035 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCTs041190035 |
|---|---|
| Public title | Implementation of first-trimester screening and prevention of preeclampsia |
| Scientific title | Implementation of first-trimester screening and prevention of preeclampsia: a stepped wedge cluster-randomized trial in Asia FORECAST - FORECAST |
| Primary sponsor | Shiozaki Arihiro |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Hong Kong;Japan;China;Japan;Taiwan;Japan;Thailand;Japan;Singapore;Japan;Philippines;Japan;Vietnam;Japan |
| Conditions | High-risk pregnancy for preterm-preeclampsia identified by screening at 11-13 weeks preeclampsia;preeclampsia |
| Interventions | Low-dose aspirin is prescribed every night from before 15 weeks to 36 weeks of gestation to prevent PE in a woman who is at the age of 18 and older, who was screened for PE in an intervention period, and who was identified as a PE high-risk… |
| Registration date | May 30, 2019 |
| Target size | 7800 |
| Registry page | jrct.niph.go.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: